セントルイスカージナルス

International Affairs Students Current Students Alumni Faculty/Staff Careers--> TOHOKU UNIVERSITYCREATING GLOBAL EXCELLENCE Search 日本語 Contact Tohoku University --> --> About Facts & Figures Facilities Organization Chart History President's Message Top Global University Project Designated National University Global Network Promotional Videos Academics Undergraduate Graduate Courses in English Exchange Programs Summer Programs Double Degree Programs Academic Calendar Syllabus Admissions Undergraduate Admissions Graduate Admissions Fees and Expenses Financial Aid Research Feature Highlights Research Releases University Research News Research Institutes Visitor Research Center Research Profiles Academic Research Staff Campus Life International Support Office IT Services Facilities Dining & Shops Campus Bus Clubs & Circles News University News Research--> Arts & Culture Health & Sports Campus & Community Press Release--> International Visit Alumni Careers Events Exhibits Music Special Event Lecture Alumni--> Map & Directions Campus Maps & Bus--> Facilities Map--> TOHOKUUNIVERSITY About Academics Admissions Research Campus Life News Events International Affairs Students Current Students Alumni Faculty/Staff Promotional Videos Subscribe to our Newsletter Map & Directions Contact Jobs & Vacancies Emergency Information Site Map 日本語 Close Home News Research New Therapeutic Tablet for the Treatment of HIV Infection News New Therapeutic Tablet for the Treatment of HIV Infection 2016-07-20 Research A new drug developed by Japanese researchers is the latest promising treatment against HIV infection. A collaborative research into elvitegravir by Professor Eiichi Kodama and Japan Tobacco Inc. showed extremely high anti-HIV activity, and effectiveness even against mutant strains that have been resistant to other classes of anti-HIV drugs. The new drug is called "Genvoya® Combination Tablets." The once daily single tablet regimen contains four active ingredients - elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide. It was approved by the US Food and Drug Administration last November for the treatment of HIV-1 infection in adults and children above the age of 12. It has since been marketed by Gilead Sciences, Inc. In Japan, the manufacturing and marketing of "Genvoya® Combination Tablets" was approved on June 17 and will be sold and distributed by Torii Pharmaceutical Co., Ltd. HIV infects and destroys important immune lymphocytes, resulting in severe immunodeficiency. In recent years, effective drugs have been developed that successfully blocked HIV replication. However, the number of pills needed in combination, as well as the emergence of new drug-resistant HIV strains, have been of growing concern. Researchers and clinicians hope the new drug will go some way towards solving both problems. Kodama worked on the research while he was at Kyoto University. He is currently with Tohoku University's International Research Institute of Disaster Science, while also serving as professor of the Graduate School of Medicine, Tohoku Medical Megabank Organization and University Hospital. * Genvoya is a registered trademark of Gilead Sciences, Inc. Contact: Eiichi N. Kodama International Research Institute of Disaster [email protected] Category University News Research Arts & Culture Health & Sports Campus & Community International Visits Alumni Careers COVID-19 Archives 2014&＃24180; 2015&＃24180; 2016&＃24180; 2017&＃24180; 2018&＃24180; 2019&＃24180; 2020&＃24180; 2021&＃24180; 2022&＃24180; 2023&＃24180; 2024&＃24180; Recent News 2024-04-10 University News Tohoku University&＃039;s New President Meets the Media 2024-04-10 Careers Recruitment Notice: Associate Professor 2024-04-03 University News Tohoku University Entrance Ceremony, Spring 2024 2024-04-02 Careers Recruitment Notice: Assistant Professor 2024-04-01 University News In Conversation with Hideo Ohno Archives Page Top About Tohoku University Academics Admissions Research Campus Life News Events International Affairs Students Alumni Promotional Videos Subscribe to our Newsletter Map & Directions Contact Tohoku University Jobs & Vacancies Emergency Information Site Map Privacy Policy Media Enquiries Parent & Family Support Public Facilities Contact Tohoku University